Nsonwu Olisaeloka, Thelwall Simon, Gerver Sarah, Guy Rebecca L, Chudasama Dimple, Hope Russell
Antimicrobial Resistance and Healthcare Associated Infections Division, UK Health Security Agency, London, United Kingdom.
Euro Surveill. 2025 May;30(17). doi: 10.2807/1560-7917.ES.2025.30.17.2400430.
Background, spp. and are included in the mandatory surveillance of bloodstream infections (BSI) in England.AimWe aimed to investigate the epidemiology of these BSIs in England April 2017-March 2022.MethodsWe extracted data on , spp. and BSI, categorised BSIs as healthcare-associated (HA) or community-associated (CA) and linked to antimicrobial susceptibility and mortality data. We used multivariable logistic regression models to assess predictors of mortality.ResultsThe incidence rate of BSI was 71.8 per 100,000 population (95% confidence interval (CI): 71.5-72.1), spp. 19.1 (95% CI: 18.9-19.3) and 7.6 (95% CI: 7.5-7.7). Most (65,467/104,957) BSI episodes were CA. Case-fatality rate was 14.8% (95% CI: 14.6-14.9) in , 20.0% (95% CI: 19.6-20.3) in spp. and 25.8% (95% CI: 25.2-26.4) in BSI. Urinary tract infection (UTI) was the most reported primary infection for (56,961/100,834), spp. (9,098/22,827) and (3,204/8,484) BSI. Insertion or manipulation of urinary catheters was reported for 26.4% (16,136/61,043) of , 41.6% (4,470 /10,734) of spp. and 49.0% (2,127/4,341) of BSI. The adjusted odds ratio (OR) of death among hospital-onset HA-BSI compared to CA-BSI was 2.0 (95% CI: 1.9-2.2) for , 2.1 (95% CI: 2.0-2.3) for spp. and 1.7 (95% CI: 1.5-2.0) for .ConclusionsAppropriate management of UTIs and urinary catheterisation is essential for reduction of these BSIs.
背景,[具体菌种1]、[具体菌种2]和[具体菌种3]被纳入英格兰血流感染(BSI)的强制监测范围。
目的
我们旨在调查2017年4月至2022年3月期间英格兰这些血流感染的流行病学情况。
方法
我们提取了关于[具体菌种1]、[具体菌种2]和[具体菌种3]血流感染的数据,将血流感染分为医疗保健相关(HA)或社区相关(CA),并与抗菌药物敏感性和死亡率数据相关联。我们使用多变量逻辑回归模型来评估死亡率的预测因素。
结果
[具体菌种1]血流感染的发病率为每10万人71.8例(95%置信区间(CI):71.5 - 72.1),[具体菌种2]为19.1例(95% CI:18.9 - 19.3),[具体菌种3]为7.6例(95% CI:7.5 - 7.7)。大多数(65,467/104,957)血流感染发作是社区相关的。[具体菌种1]血流感染的病死率为14.8%(95% CI:14.6 - 14.9),[具体菌种2]为20.0%(95% CI:19.6 - 20.3),[具体菌种3]为25.8%(95% CI:25.2 - 26.4)。尿路感染(UTI)是[具体菌种1](56,961/100,834)、[具体菌种2](9,098/22,827)和[具体菌种3](3,204/8,484)血流感染中报告最多的原发性感染。在[具体菌种1]血流感染中,26.4%(16,136/61,043)报告有导尿管插入或操作,[具体菌种2]为41.6%(4,470 /10,734),[具体菌种3]为49.0%(2,127/4,341)。与社区相关血流感染相比,医院获得性HA - BSI中死亡的调整优势比(OR),[具体菌种1]为2.0(95% CI:1.9 - 2.2),[具体菌种2]为2.1(95% CI:2.0 - 2.3),[具体菌种3]为1.7(95% CI:1.5 - 2.0)。
结论
适当管理尿路感染和导尿对于减少这些血流感染至关重要。